(Canadian Medical Association Journal) An increased dosage of Tamiflu for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study in CMAJ.

Further information:

Article source

Related posts:

1. H1N1 learnings: Risk factors for severe outcomes among patients admitted to hospital with H1N1
2. Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu
3. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
4. Tamiflu boost not needed for severely ill
5. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis